Namil General Foods Co.

5 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NO PROCESS2 refused lines

  No scheduled process filed

  The manufacturer appeared not to have filed a scheduled process with FDA, which 21 CFR Part 108 requires for low-acid canned and acidified foods, so the product is treated as made under insanitary conditions.

• MFRHACCP1 refused line

  Seafood HACCP requirements not met

  The seafood appeared to have been processed without meeting the seafood HACCP requirements in 21 CFR 123.6(a) and 123.8(a), so it is treated as prepared under insanitary conditions.

Questions about Namil General Foods Co.

Is Namil General Foods Co. on an FDA import alert?

Yes. As of October 26, 2026, Namil General Foods Co. is on the red list of FDA Import Alert 16-120, “Seafood from processors not in compliance with HACCP”, for rte lacf pacific saury (mackerel pike); rte lacf kimchi and pacific saury; rte lacf mackerel; FDA published the listing on September 3, 2025.

Has FDA refused shipments from Namil General Foods Co.?

Yes. FDA refused 3 shipment lines from Namil General Foods Co. between June 20, 2024 and May 1, 2026. The most recent, on May 1, 2026, was saury, charged as MFRHACCP (seafood haccp requirements not met).

Why did FDA refuse Namil General Foods Co.'s shipments?

The most frequent charges are NO PROCESS (no scheduled process filed, 2 lines) and MFRHACCP (seafood haccp requirements not met, 1 line).

When was Namil General Foods Co. last inspected by FDA?

FDA's most recent inspection of Namil General Foods Co. with a final classification is dated March 13, 2025 and was classified OAI (Official Action Indicated).

What is Namil General Foods Co.'s FEI number?

Namil General Foods Co.'s FDA Establishment Identifier (FEI) is 3010102402.

Can shipments from Namil General Foods Co. still enter the U.S.?

Shipments of rte lacf pacific saury (mackerel pike); rte lacf kimchi and pacific saury; rte lacf mackerel from Namil General Foods Co. can be detained without physical examination under Import Alert 16-120; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).